Wells Fargo & Company Lyra Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 17,596 shares of LYRA stock, worth $3,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,596
Previous 17,618 0.12%
Holding current value
$3,167
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.24 - $0.34 $5 - $7
-22 Reduced 0.12%
17,596 $4,000
Q2 2024

Aug 13, 2024
BUY
$0.26 - $6.25 $4,515 - $108,543
17,367 Added 6919.12%
17,618 $4,000
Q1 2024

May 10, 2024
BUY
$4.55 - $6.53 $18 - $26
4 Added 1.62%
251 $1,000
Q4 2023

Feb 09, 2024
BUY
$2.82 - $5.24 $73 - $136
26 Added 11.76%
247 $1,000
Q3 2023

Nov 13, 2023
BUY
$2.95 - $4.8 $300 - $489
102 Added 85.71%
221 $0
Q2 2023

Aug 15, 2023
BUY
$1.98 - $4.33 $9 - $21
5 Added 4.39%
119 $0
Q1 2023

May 12, 2023
BUY
$1.95 - $3.09 $1 - $3
1 Added 0.88%
114 $0
Q4 2022

Feb 13, 2023
BUY
$2.44 - $5.42 $7 - $16
3 Added 2.73%
113 $0
Q3 2022

Nov 14, 2022
SELL
$4.95 - $6.6 $4 - $6
-1 Reduced 0.9%
110 $1,000
Q2 2022

Aug 12, 2022
SELL
$4.12 - $7.51 $1,755 - $3,199
-426 Reduced 79.33%
111 $1,000
Q3 2021

Nov 15, 2021
BUY
$6.06 - $9.43 $84 - $132
14 Added 2.68%
537 $5,000
Q2 2021

Aug 16, 2021
SELL
$6.91 - $12.59 $10,793 - $19,665
-1,562 Reduced 74.92%
523 $4,000
Q1 2021

May 13, 2021
SELL
$10.38 - $15.61 $14,905 - $22,415
-1,436 Reduced 40.78%
2,085 $24,000
Q4 2020

Feb 09, 2021
BUY
$9.28 - $13.88 $22,624 - $33,839
2,438 Added 225.12%
3,521 $40,000
Q3 2020

Nov 05, 2020
SELL
$10.61 - $13.96 $10,620 - $13,973
-1,001 Reduced 48.03%
1,083 $12,000
Q2 2020

Aug 13, 2020
BUY
$10.91 - $18.56 $22,736 - $38,679
2,084 New
2,084 $24,000

Others Institutions Holding LYRA

# of Institutions
62
Shares Held
32.2M
Call Options Held
21.1K
Put Options Held
400
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email